您的购物车当前为空
别名 HMPL-813 succinate
Epitinib succinate (HMPL-813 succinate) 是一种具有口服活性和脑渗透性的 EGFR 酪氨酸激酶抑制剂,可用于癌症研究。

Epitinib succinate (HMPL-813 succinate) 是一种具有口服活性和脑渗透性的 EGFR 酪氨酸激酶抑制剂,可用于癌症研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 696 | In Stock | |
| 2 mg | ¥ 987 | In Stock | |
| 5 mg | ¥ 1,730 | In Stock | |
| 10 mg | ¥ 2,590 | In Stock | |
| 25 mg | ¥ 4,130 | In Stock | |
| 50 mg | ¥ 5,590 | In Stock | |
| 100 mg | ¥ 7,560 | In Stock | |
| 500 mg | ¥ 15,100 | In Stock |
Epitinib succinate 相关产品
| 产品描述 | Epitinib succinate (HMPL-813 succinate) is an orally active and brain penetration EGFR tyrosine kinase inhibitor and can be used in studies about cancer. |
| 别名 | HMPL-813 succinate |
| 分子量 | 548.59 |
| 分子式 | C28H32N6O6 |
| CAS No. | 2252334-12-4 |
| Smiles | OC(=O)CCC(O)=O.CCN1CCN(CC1)C(=O)Nc1cc2c(Nc3cccc(c3)C#C)ncnc2cc1OC |
| 密度 | no data available |
| 颜色 | Yellow |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||
| 溶解度信息 | DMSO: 1 mg/mL (1.82 mM), Sonication is recommended. | ||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1 mg/mL (1.82 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||
溶液配制表 | |||||||||||
DMSO
| |||||||||||
评论内容